Insulet Corporation (PODD)
NASDAQ: PODD · IEX Real-Time Price · USD
197.19
+1.03 (0.53%)
At close: Jul 2, 2024, 4:00 PM
195.50
-1.69 (-0.86%)
After-hours: Jul 2, 2024, 7:06 PM EDT
Insulet Employees
Insulet had 3,000 employees as of December 31, 2023. The number of employees increased by 400 or 15.38% compared to the previous year.
Employees
3,000
Change (1Y)
400
Growth (1Y)
15.38%
Revenue / Employee
$593,567
Profits / Employee
$78,000
Market Cap
13.81B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,000 | 400 | 15.38% |
Dec 31, 2022 | 2,600 | 300 | 13.04% |
Dec 31, 2021 | 2,300 | 400 | 21.05% |
Dec 31, 2020 | 1,900 | 550 | 40.74% |
Dec 31, 2019 | 1,350 | 181 | 15.48% |
Dec 31, 2018 | 1,169 | 312 | 36.41% |
Dec 31, 2017 | 857 | 217 | 33.91% |
Dec 31, 2016 | 640 | -7 | -1.08% |
Dec 31, 2015 | 647 | 128 | 24.66% |
Dec 31, 2014 | 519 | 41 | 8.58% |
Dec 31, 2013 | 478 | -60 | -11.15% |
Dec 31, 2012 | 538 | -38 | -6.60% |
Dec 31, 2011 | 576 | 266 | 85.81% |
Dec 31, 2010 | 310 | 34 | 12.32% |
Dec 31, 2009 | 276 | -18 | -6.12% |
Dec 31, 2008 | 294 | 47 | 19.03% |
Dec 31, 2007 | 247 | -47 | -15.99% |
Dec 31, 2006 | 294 | 47 | 19.03% |
Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Quest Diagnostics | 48,000 |
Revvity | 11,500 |
Medpace Holdings | 5,900 |
BioMarin Pharmaceutical | 3,401 |
Natera | 3,293 |
Incyte | 2,524 |
Neurocrine Biosciences | 1,400 |
PODD News
- 11 days ago - Insulet's SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes - Business Wire
- 12 days ago - Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands - Business Wire
- 12 days ago - Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates - Business Wire
- 5 weeks ago - Insulet to Present at the Jefferies Global Healthcare Conference - Business Wire
- 7 weeks ago - Insulet misses first-quarter profit estimates as marketing costs weigh - Reuters
- 7 weeks ago - Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year - Business Wire
- 2 months ago - Insulet's 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth - Business Wire
- 3 months ago - Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 - Business Wire